By ,
Published November 19, 2015
Drugmaker Gilead Sciences Inc said on Thursday the U.S. Food and Drug Administration approved the expanded use of its blockbuster hepatitis C drug, Harvoni.
The drug can now be used to treat patients with subtypes of chronic hepatitis C virus (HCV) and in patients who are co-infected with Human Immunodeficiency Virus (HIV), Gilead said in a statement
(Reporting by Rosmi Shaji in Bengaluru; Editing by Anil D'Silva)
https://www.foxnews.com/health/fda-approves-gileads-hepatitis-c-drug-for-expanded-use